Mirae Asset Global ETFs Holdings
PRCT icon

Mirae Asset Global ETFs Holdings’s Procept Biorobotics PRCT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
498,272
+16,972
+4% +$425K 0.01% 644
2026
Q1 		$12M Sell
481,300
-218,671
-31% -$6.16M 0.02% 604
2025
Q4 		$22M Buy
699,971
+14,892
+2% +$494K 0.03% 430
2025
Q3 		$24.5M Sell
685,079
-2,643
-0.4% -$121K 0.04% 394
2025
Q2 		$39.6M Buy
687,722
+25,903
+4% +$1.46M 0.08% 253
2025
Q1 		$38.6M Buy
661,819
+30,685
+5% +$2.1M 0.08% 241
2024
Q4 		$50.8M Sell
631,134
-7,416
-1% -$634K 0.11% 203
2024
Q3 		$51.2M Sell
638,550
-45,183
-7% -$3.21M 0.12% 184
2024
Q2 		$41.8M Buy
+683,733
New +$40.7M 0.1% 208

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PRCT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Procept Biorobotics (PRCT) stake by 3.5% in Q2 2026, buying an estimated $425K and bringing the position to 498,272 shares worth $11.3M. The position accounts for 0.01% of the portfolio, ranked #644.

Mirae Asset Global ETFs Holdings first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $51.2M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 498,272 shares of Procept Biorobotics worth $11.3M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 16,972 Procept Biorobotics shares in Q2 2026, an estimated $425K.
  • Procept Biorobotics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #644 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Procept Biorobotics position peaked at $51.2M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.